Skip to content
HowShorted

UroGen Pharma Ltd. short interest in 2021

In 2021, UroGen Pharma Ltd.'s disclosed short interest ran from 11.96% of shares outstanding on 15 Jan 2021 to 8.06% on 31 Dec 2021, a change of -3.90 percentage points. The year's high was 12.51% on 26 Feb 2021 and its low 7.31% on 15 Nov 2021, averaging 9.84% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.16 days on 29 Oct 2021. Full history: UroGen Pharma Ltd..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for UroGen Pharma Ltd. in 2021

2021 in figures

Start of year
11.96% (15 Jan 2021)
End of year
8.06% (31 Dec 2021)
Change
-3.90 pp
High
12.51% (26 Feb 2021)
Low
7.31% (15 Nov 2021)
Average
9.84%
Highest days to cover
36.16 (29 Oct 2021)
SEC filings marked
9

Every report in 2021

UroGen Pharma Ltd. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202111.96%14.89
29 Jan 202111.85%15.98
12 Feb 202112.32%16.04
26 Feb 202112.51%23.73
15 Mar 202111.08%9.25
31 Mar 202110.47%9.9610-K filed, results (8-K)
15 Apr 202110.64%17.57
30 Apr 202110.50%24.65
14 May 202110.47%20.0410-Q filed, results (8-K)
28 May 202111.01%24.35
15 Jun 202110.20%19.76
30 Jun 20219.55%14.11
15 Jul 20219.40%9.82results (8-K)
30 Jul 20219.21%15.70
13 Aug 20219.94%16.2510-Q filed, results (8-K)
31 Aug 20219.89%21.15
15 Sep 20219.19%25.78
30 Sep 20218.29%28.58
15 Oct 20217.85%34.89
29 Oct 20217.82%36.16
15 Nov 20217.31%13.5810-Q filed, results (8-K)
30 Nov 20218.13%8.29
15 Dec 20218.44%13.73
31 Dec 20218.06%11.89

See also: UroGen Pharma Ltd.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.